Category: Compound Profiles

Semax is a synthetic heptapeptide (seven amino acids) structurally based on the ACTH(4-7) fragment of adrenocorticotropic hormone, with a Pro-Gly-Pro extension that increases its stability against enzymatic degradation. It is studied in preclinical research as a melanocortin-fragment analog and tool compound for investigating neurochemistry in animal and cell-culture research models. Semax is a fully synthetic […]

Kisspeptin vs HCG: How the Research Compares Kisspeptin and HCG both appear in reproductive-endocrinology research, but they act at opposite ends of the hypothalamic-pituitary-gonadal axis: upstream signaling versus a downstream gonadal receptor. At a glance Property Kisspeptin HCG Class Synthetic peptide (Kisspeptin-10) Glycoprotein hormone Primary research target KISS1R (upstream of GnRH) LH/CG receptor (gonadal) Research […]

BPC-157 vs GHK-Cu: How the Research Compares BPC-157 and GHK-Cu both appear across tissue-repair research, but one is a pentadecapeptide studied in angiogenesis and connective-tissue models and the other a copper tripeptide studied in dermal and extracellular-matrix models. At a glance Property BPC-157 GHK-Cu Class Synthetic pentadecapeptide Copper tripeptide (Gly-His-Lys-Cu) Primary research target NO / […]

Tesofensine vs 5-Amino-1MQ: How the Research Compares Tesofensine and 5-Amino-1MQ are both studied in metabolic research models, but they act through entirely different mechanisms: central monoamine reuptake versus a metabolic enzyme. At a glance Property Tesofensine 5-Amino-1MQ Class Triple monoamine reuptake inhibitor Small-molecule NNMT inhibitor Primary research target DA / NE / 5-HT transporters NNMT […]

MOTS-c vs 5-Amino-1MQ: How the Research Compares MOTS-c and 5-Amino-1MQ are both studied in metabolic research, but one is a mitochondrial-derived peptide and the other a small-molecule enzyme inhibitor with distinct targets. At a glance Property MOTS-c 5-Amino-1MQ Class Mitochondrial-derived peptide Small-molecule NNMT inhibitor Primary research target AMPK / metabolic homeostasis NNMT enzyme Research domain […]

Tesamorelin vs Ipamorelin: How the Research Compares Tesamorelin and Ipamorelin are both studied in growth-hormone-axis research, but they act on two different arms of GH release: the GHRH receptor and the growth-hormone-secretagogue receptor. At a glance Property Tesamorelin Ipamorelin Class Stabilized GHRH analog Selective GH secretagogue (peptide) Primary research target GHRH receptor GHS-R1a (ghrelin receptor) […]

CJC-1295 with DAC vs CJC-1295 No DAC: How the Research Compares Both forms of CJC-1295 are synthetic analogs of growth-hormone-releasing hormone built on a modified GRF(1-29) sequence; the key research distinction is the Drug Affinity Complex (DAC) and its effect on half-life. At a glance Property CJC-1295 with DAC CJC-1295 No DAC Class GHRH(1-29) analog […]

PT-141 vs MT-2 (Melanotan 2): How the Research Compares PT-141 (bremelanotide) and MT-2 (Melanotan II) are both synthetic cyclic heptapeptides studied as melanocortin-receptor agonists, but research interest centers on different receptor subtypes. At a glance Property PT-141 MT-2 (Melanotan 2) Class Synthetic cyclic heptapeptide Synthetic cyclic heptapeptide Primary research target MC3R / MC4R (central) MC1R […]

GLOW Complex: What the Research Shows GLOW Complex is a combination research blend of three peptides (GHK-Cu, BPC-157, and TB-500) supplied at a 50:10:10 ratio (70 mg total). It is studied across tissue-repair, dermal extracellular-matrix, and angiogenesis research models. As a multi-component blend, GLOW Complex is a research preparation rather than a single molecular entity. […]

MT-2 (Melanotan II): What the Research Shows MT-2, or Melanotan II, is a synthetic cyclic heptapeptide and a melanocortin-receptor agonist. It is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH), studied in preclinical research within melanogenesis and pigmentation models. MT-2 does not occur as a discrete protein in the human proteome, which makes it a fully […]